Thus, due to the strong association of CVD risk with the epigenetic clock and morbidity/mortality, any effort should be made to reduce the low-grade chronic inflammatory state in obesity (e.g., through the administration of a long-term BWRP) [43]. This evidence concerns the gene CLOCK and obesity disorder.